Despite multimodal treatment, outcomes for metastatic RPS are poor with median overall survival of 16 months.  This consensus document combines the available literature regarding the management of multifocally recurrent or metastastic RPS with the practical expertise of high-volume   sarcoma centers from multiple countries.

Find full article here.